Enerkem has succeeded in producing a new high-performance biofuel that has a research octane number of up to 112 -- exceeding regular motor gasoline's average octane rating by 20 points. The waste-to-biofuels and chemicals producer used bio-dimethyl ether to develop biofuel rich in paraffins.
Boston Scientific entered a deal to buy NxThera, which makes the Rezum system for treating symptomatic enlarged prostate, for up to $306 million in cash upfront plus potential commercial milestone payments of up to $100 million. The companies aim to spin off a firm to assess the use of NxThera's product for kidney and prostate cancer after completion of the deal, which could happen in the second quarter.
Cantel Medical agreed to pay $21.1 million upfront and $3.7 million in future earnouts for Belgian health care software developer Aexis Medical. The acquisition will help Cantel enter the worldwide market for health care information analytics in infection prevention, which will allow it to move its business strategy forward and improve its position for future growth, said company President and CEO Jorgen Hansen.
A round of Series A1 funding led by Illumina Ventures brought in $2.5 million for Pittsburgh-based Cernostics, bringing the total funding to $13 million. The proceeds will be used for expanding clinical and market development studies for the company's TissueCypher Barrett's Esophagus Assay, a test used in patients with Barrett's esophagus to predict esophageal cancer risk.
A report from The Business Research Co. found the minor orthopedic replacement implant market will see an annual growth rate of more than 7%, reaching $2.2 billion in 2021, because of an increased rate of fractures and arthritis. Uncertainty surrounding economic, regulatory and reimbursement trends will encourage big manufacturers to shift to shoulder, wrist, foot and ankle replacement implants, while a major trend in the market toward small bone plating and other minor joint procedures will continue, according to the report.
The Scoliosis Research Society and the International Spine Study Group Foundation, Zimmer Biomet, Medtronic, K2M, Globus Medical and NuVasive agreed to work together to finish the continuation of an earlier study on the operative and nonoperative treatment of patients with adult symptomatic lumbar scoliosis. The continuation study, which is being conducted at 10 US and Canadian sites, will further observe 258 patients remaining from the previous study for eight years.
Agendia's next-generation sequencing-based MammaPrint BluePrint kit, designed for breast cancer recurrence risk testing and molecular subtyping, was granted CE mark approval by European regulators. The kit is an RNA-sequencing based version of the company's MammaPrint and BluePrint tests.
European regulators gave Saladax Biomedical CE mark approval for its MyCare Total Risperidone Assay Kit and MyCare Paliperidone Assay Kit, the company's first two products in its MyCare Psychiatry line of rapid tests for antipsychotic medications. The tests, which are intended for measuring total paliperidone or risperidone in the blood, can provide results in an hour from a blood draw in some settings and within two days in other settings.
The future of human health rests on a kind of social contract called Health Citizenship, in which individuals and the health care system have an implied set of rights and responsibilities, writes FasterCures Executive Director Tanisha Carino. To bend the arc of progress, tomorrow's clinicians will need to recruit and engage patients in clinical trials and understand where rights and responsibilities exist; and payers in the public and private sectors must realign payments to incentivize higher-quality, more efficient care, Carino writes.
As the All of Us Research Program gets underway, researchers are recruiting 1 million volunteers from all racial and ethnic groups who are willing to share detailed genetic, medical and lifestyle data. Critics say the study is too complex and expensive to succeed and duplicates smaller studies, but no other program aims for a similarly diverse, representative sampling of Americans.